Application 204852
- Type
- ANDA
- Sponsor
- AUROLIFE PHARMA LLC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TRAZODONE HYDROCHLORIDE | TRAZODONE HYDROCHLORIDE | TABLET;ORAL | 50MG | No | No |
| 002 | TRAZODONE HYDROCHLORIDE | TRAZODONE HYDROCHLORIDE | TABLET;ORAL | 100MG | No | No |
| 003 | TRAZODONE HYDROCHLORIDE | TRAZODONE HYDROCHLORIDE | TABLET;ORAL | 150MG | No | No |
| 004 | TRAZODONE HYDROCHLORIDE | TRAZODONE HYDROCHLORIDE | TABLET;ORAL | 300MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 13107-079 | Trazodone Hydrochloride | Trazodone Hydrochloride | Aurolife Pharma, LLC | ANDA | Current |
| 13107-080 | Trazodone Hydrochloride | Trazodone Hydrochloride | Aurolife Pharma, LLC | ANDA | Current |
| 13107-081 | Trazodone Hydrochloride | Trazodone Hydrochloride | Aurolife Pharma, LLC | ANDA | Current |
| 13107-082 | Trazodone Hydrochloride | Trazodone Hydrochloride | Aurolife Pharma, LLC | ANDA | Current |